Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05156268
Title A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

endometrial carcinoma

uterine carcinosarcoma

Therapies

Olaparib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center Recruiting Basking Ridge New Jersey 07920 United States Details
Maria Rubinstein Recruiting Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Recruiting Montvale New Jersey 07645 United States Details
Maria Rubinstein Recruiting Commack New York 11725 United States Details
Maria Rubinstein Recruiting Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Maria Rubinstein Recruiting Rockville Centre New York 11553 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field